Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome

  • Helen Fogarty
  • Liam Townsend
  • Hannah Morrin
  • Azaz Ahmad
  • Claire Comerford
  • Ellie Karampini
  • Hanna Englert
  • Mary Byrne
  • Colm Bergin
  • Jamie M O'Sullivan
  • Ignacio Martin-Loeches
  • Parthiban Nadarajan
  • Ciaran Bannan
  • Patrick W Mallon
  • Gerard F Curley
  • Roger J S Preston
  • Aisling M Rehill
  • Dennis McGonagle
  • Cliona Ni Cheallaigh
  • Ross I Baker
  • Thomas Renné
  • Soracha E Ward
  • James S O' Donnell
  • Irish COVID-19 Vasculopathy Study (iCVS) investigators

Abstract

BACKGROUND: Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS-CoV-2 infection. The biological mechanisms underlying this "long COVID" syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID-19.

OBJECTIVES: To assess whether endothelial cell activation may be sustained in convalescent COVID-19 patients and contribute to long COVID pathogenesis.

PATIENTS AND METHODS: Fifty patients were reviewed at a median of 68 days following SARS-CoV-2 infection. In addition to clinical workup, acute phase markers, endothelial cell (EC) activation and NETosis parameters and thrombin generation were assessed.

RESULTS: Thrombin generation assays revealed significantly shorter lag times (p < .0001, 95% CI -2.57 to -1.02 min), increased endogenous thrombin potential (p = .04, 95% CI 15-416 nM/min), and peak thrombin (p < .0001, 95% CI 39-93 nM) in convalescent COVID-19 patients. These prothrombotic changes were independent of ongoing acute phase response or active NETosis. Importantly, EC biomarkers including von Willebrand factor antigen (VWF:Ag), VWF propeptide (VWFpp), and factor VIII were significantly elevated in convalescent COVID-19 compared with controls (p = .004, 95% CI 0.09-0.57 IU/ml; p = .009, 95% CI 0.06-0.5 IU/ml; p = .04, 95% CI 0.03-0.44 IU/ml, respectively). In addition, plasma soluble thrombomodulin levels were significantly elevated in convalescent COVID-19 (p = .02, 95% CI 0.01-2.7 ng/ml). Sustained endotheliopathy was more frequent in older, comorbid patients, and those requiring hospitalization. Finally, both plasma VWF:Ag and VWFpp levels correlated inversely with 6-min walk tests.

CONCLUSIONS: Collectively, our findings demonstrate that sustained endotheliopathy is common in convalescent COVID-19 and raise the intriguing possibility that this may contribute to long COVID pathogenesis.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1538-7933
DOIs
StatusVeröffentlicht - 10.2021
PubMed 34375505